相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Rapid Depletion of Free Vancomycin in Medium in the Presence of beta-Lactam Antibiotics and Growth Restoration in Staphylococcus aureus Strains with beta-Lactam-Induced Vancomycin Resistance
Chie Yanagisawa et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Intracellular Activity of Antibiotics in a Model of Human THP-1 Macrophages Infected by a Staphylococcus aureus Small-Colony Variant Strain Isolated from a Cystic Fibrosis Patient: Study of Antibiotic Combinations
Hoang Anh Nguyen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Severity of Gentamicin's Nephrotoxic Effect on Patients with Infective Endocarditis: A Prospective Observational Cohort Study of 373 Patients
Kristine Buchholtz et al.
CLINICAL INFECTIOUS DISEASES (2009)
Complicated Skin and Skin-Structure Infections and Catheter-Related Bloodstream Infections: Noninferiority of Linezolid in a Phase 3 Study
Mark H. Wilcox et al.
CLINICAL INFECTIOUS DISEASES (2009)
Vancomycin in Combination with Other Antibiotics for the Treatment of Serious Methicillin-Resistant Staphylococcus aureus Infections
Stan Deresinski
CLINICAL INFECTIOUS DISEASES (2009)
Vancomycin Therapeutic Guidelines: A Summary of Consensus Recommendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists
Michael J. Rybak et al.
CLINICAL INFECTIOUS DISEASES (2009)
Initial Low-Dose Gentamicin for Staphylococcus aureus Bacteremia and Endocarditis Is Nephrotoxic
Sara E. Cosgrove et al.
CLINICAL INFECTIOUS DISEASES (2009)
Salvage Treatment for Persistent Methicillin-Resistant Staphylococcus aureus Bacteremia: Efficacy of Linezolid With or Without Carbapenem
Hee-Chang Jang et al.
CLINICAL INFECTIOUS DISEASES (2009)
hVISA/VISA: diagnostic and therapeutic problems
Judit Szabo
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2009)
Host Defense and Pathogenesis in Staphylococcus aureus Infections
Frank R. DeLeo et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2009)
Methicillin-Resistant Staphylococcus aureus Central Line-Associated Bloodstream Infections in US Intensive Care Units, 1997-2007
Deron C. Burton et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Occurrence of vancomycin-tolerant and heterogeneous vancomycin-intermediate strains (hVISA) among Staphylococcus aureus causing bloodstream infections in nine USA hospitals
Helio S. Sader et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Accessory Gene Regulator Dysfunction: An Advantage for Staphylococcus aureus in Health-Care Settings?
George Sakoulas et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Clinical Features of Heteroresistant Vancomycin-Intermediate Staphylococcus aureus Bacteremia versus Those of Methicillin-Resistant S. aureus Bacteremia
Yasmin Maor et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Evolution of virulence in epidemic community-associated methicillin-resistant Staphylococcus aureus
Min Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists
M. Rybak et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2008)
Emergence of multidrug-resistant, community-associated, methicillin-resistant Staphylococcus aureus clone USA300 in men who have sex with men
Binh An Diep et al.
ANNALS OF INTERNAL MEDICINE (2008)
Clinical experience with daptomycin for the treatment of patients with documented gram-positive septic arthritis
Graeme N. Forrest et al.
ANNALS OF PHARMACOTHERAPY (2008)
Activities of Daptomycin and comparative antimicrobials, singly and in combination, against extracellular and intracellular Staphylococcus aureus aend its stable small-colony variant in human monocyte-derived macrophages and in broth
Aldona L. Baltch et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Evaluation of daptomycin pharmacodynamics and resistance at various dosage regimens against Staphylococcus aureus isolates with reduced susceptibilities to daptomycin in an in vitro pharmacodynamic model with simulated endocardial vegetations
Warren E. Rose et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Addition of rifampin to standard therapy for treatment of native valve infective endocarditis caused by Staphylococcus aureus
David J. Riedel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Adjunctive use of rifampin for the treatment of Staphylococcus aureus infections
Joshua Perlroth et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
A population-based study of the incidence and molecular epidemiology of methicillin-resistant Staphylococcus aureus disease in San francisco, 2004-2005
Catherine Liu et al.
CLINICAL INFECTIOUS DISEASES (2008)
Current treatment options for community-acquired methicillin-resistant Staphylococcus aureus infection
Robert C. Moellering
CLINICAL INFECTIOUS DISEASES (2008)
Role of folate antagonists in the treatment of methicillin-resistant Staphylococcus aureus infection
Richard A. Proctor
CLINICAL INFECTIOUS DISEASES (2008)
Are community-associated methicillin-resistant Staphylococcus aureus (MRSA) strains replacing traditional nosocomial MRSA strains?
Kyle J. Popovich et al.
CLINICAL INFECTIOUS DISEASES (2008)
Effect of antibiotics, alone and in combination, on Panton-Valentine leukocidin production by a Staphylococcus aureus reference strain
O. Dumitrescu et al.
CLINICAL MICROBIOLOGY AND INFECTION (2008)
Glycopeptide Bone Penetration in Patients with Septic Pseudoarthrosis of the Tibia
Silvia Garazzino et al.
CLINICAL PHARMACOKINETICS (2008)
Efficacy and pharmacodynamics of linezolid, alone and in combination with rifampicin, in an experimental model of methicillin-resistant Staphylococcus aureus endocarditis
Thomas Tsaganos et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci:: a Phase 3, multicentre, double-blind, randomized study
I. Florescu et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
An antidote for Staphylococcus aureus pneumonia?
Frank R. DeLeo et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
New antimicrobial agents as therapy for resistant gram-positive cocci
J. R. Lentino et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2008)
Invasive methicillin-resistant Staphylococcus aureus infections in the United States
R. Monina Klevens et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Evaluation of daptomycin treatment of Staphylococcus aureus bacterial endocarditis:: an in vitro and in vivo simulation using historical and current dosing strategies
Warren E. Rose et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Point:: Vancomycin is not obsolete for the treatment of infection caused by methicillin-resistant Staphylococcus aureus
John F. Mohr et al.
CLINICAL INFECTIOUS DISEASES (2007)
Counterpoint:: Vancomycin and Staphylococcus aureus -: An antibiotic enters obsolescence
Stan Deresinski
CLINICAL INFECTIOUS DISEASES (2007)
Comparative activities of daptomycin, linezolid, and tigecycline against catheter-related methicillin-resistant Staphylococcus bacteremic isolates embedded in biofilm
Issam Raad et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Global analysis of community-associated methicillin-resistant Staphylococcus aureus exoproteins reveals molecules produced in vitro and during infection
Christopher Burlak et al.
CELLULAR MICROBIOLOGY (2007)
Effect of antibiotics on Stahylococcus aureus producing Panton-Valentine leukocidin
Oana Dumitrescu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Pharmacokinetic/pharmacodynamic analysis of vancomycin in ICU patients
Maria del Mar Fernandez de Gatta Garcia et al.
INTENSIVE CARE MEDICINE (2007)
Impact of antibiotics on expression of virulence-associated exotoxin genes in methicillin-sensitive and methicillin-resistant Staphylococcus aureus
Dennis L. Stevens et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Activity of daptomycin alone and in combination with rifampin and gentamicin against Staphylococcus aureus assessed by time-kill methodology
Kim Credito et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Serum bactericidal activities of high-dose daptomycin with and without coadministration of gentamicin against isolates of Staphylococcus aureus and Enterococcus species
C. Andrew DeRyke et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections -: Efficacy and toxicity
Levita K. Hidayat et al.
ARCHIVES OF INTERNAL MEDICINE (2006)
Predictors of mortality for methicillin-resistant Staphylococcus aureus health-care-associated pneumonia -: Specific evaluation of vancomycin pharmacokinetic indices
Meghan N. Jeffres et al.
CHEST (2006)
Bactericidal activity of orally available agents against methicillin-resistant Staphylococcus aureus
Anjum S. Kaka et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus
Vance G. Fowler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
In vitro and in vivo assessment of linezolid combined with ertapenem:: a highly synergistic combination against methicillin-resistant Staphylococcus aureus
Cedric Jacqueline et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Impaired target site penetration of vancomycin in diabetic patients following cardiac surgery
K Skhirtladze et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Induction of daptomycin heterogeneous susceptibility in Staphylococcus aureus by exposure to vancomycin
G Sakoulas et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Daptomycin-rifampin for a recurrent MRSA joint infection unresponsive to vancomycin-based therapy
CA Burns
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2006)
Novel mechanism of antibiotic resistance originating in vancomycin-intermediate Staphylococcus aureus
LZ Cui et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Multiple combination bactericidal testing of staphylococcal biofilms from implant-associated infections
R Saginur et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Management of persistent Bacteremia caused by methicillin-resistant Staphylococcus aureus: A survey of infectious diseases consultants
Jeffrey C. Hageman et al.
CLINICAL INFECTIOUS DISEASES (2006)
Etest synergy testing of clinical isolates of Staphylococcus aureus demonstrating heterogeneous resistance to vancomycin
BT Tsuji et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2006)
Linezolid versus vancomycin for Staphylococcus aureus bacteraemia:: pooled analysis of randomized studies
AF Shorr et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Pleuropulmonary complications of Panton-Valentine leukocidin-positive community-acquired methicillin-resistant Staphylococcus aureus -: Importance of treatment with antimicrobials inhibiting exotoxin production
ST Micek et al.
CHEST (2005)
Experimental study on the efficacy of combinations of glycopeptides and β-lactams against Staphylococcus aureus with reduced susceptibility to glycopeptides
A Domenech et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Short-course gentamicin in combination with Daptomycin or vancomycin against Staphylococcus aureus in an in vitro pharmacodynamic model with simulated endocardial vegetations
BT Tsuji et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Does linezolid cause lactic acidosis by inhibiting mitochondrial protein synthesis?
L Palenzuela et al.
CLINICAL INFECTIOUS DISEASES (2005)
Infective endocarditis - Diagnosis, antimicrobial therapy, and management of complications - A statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association - Executive summary
LM Baddour et al.
CIRCULATION (2005)
Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections
J Weigelt et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Use of long-acting tetracyclines for methicillin-resistant Staphylococcus aureus infections:: Case series and review of the literature
JJ Ruhe et al.
CLINICAL INFECTIOUS DISEASES (2005)
Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles
LG Miller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
In vitro and in vivo synergistic activities of linezolid combined with subinhibitory concentrations of imipenem against methicillin-resistant Staphylococcus aureus
C Jacqueline et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Current concepts - Treatment of infections associated with surgical implants
RO Darouiche
NEW ENGLAND JOURNAL OF MEDICINE (2004)
In vivo efficacy of linezolid in combination with gentamicin for the treatment of experimental endocarditis due to methicillin-resistant Staphylococcus aureus
C Jacqueline et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2004)
Nosocomial bloodstream infections in US hospitals: Analysis of 24,179 cases from a prospective nationwide surveillance study
H Wisplinghoff et al.
CLINICAL INFECTIOUS DISEASES (2004)
Synergy of daptomycin with oxacillin and other β-lactams against methicillin-resistant Staphylococcus aureus
KH Rand et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Impact of high-inoculum Staphylococcus aureus on the activities of nafcillin, vancomycin, linezolid, and daptomycin, alone and in combination with gentamicin, in an in vitro pharmacodynamic model
KL LaPlante et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy
PA Moise-Broder et al.
CLINICAL INFECTIOUS DISEASES (2004)
The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections
RD Arbeit et al.
CLINICAL INFECTIOUS DISEASES (2004)
Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia
G Sakoulas et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2004)
In vitro killing of community-associated methicillin-resistant Staphylococcus aureus with drug combinations
SA Shelburne et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
In vitro activities of daptomycin, linezolid, and quinupristin-dalfopristin against a challenge panel of staphylococci and enterococci, including vancomycin-intermediate Staphylococcus aureus and vancomycin-resistant Enterococcus faecium
LA Jevitt et al.
MICROBIAL DRUG RESISTANCE (2003)
Drotrecogin alfa (activated) improves in-hospital and 90-day survival in patients with severe sepsis and community-acquired pneumonia
RG Wunderink et al.
CHEST (2003)
Efficacy of linezolid alone or in combination with vancomycin for treatment of experimental endocarditis due to methicillin-resistant Staphylococcus aureus
FY Chiang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Efficacy of linezolid plus rifampin in an experimental model of methicillin-susceptible Staphylococcus aureus endocarditis
CF Dailey et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Efficacy of daptomycin in experimental endocarditis due to methicillin-resistant Staphylococcus aureus
G Sakoulas et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
In vitro activity of linezolid alone and in combination with gentamicin, vancomycin or rifampicin against methicillin-resistant Staphylococcus aureus by time-kill curve methods
C Jacqueline et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Quinupristin-dalfopristin and linezolid: Evidence and opinion
GM Eliopoulos
CLINICAL INFECTIOUS DISEASES (2003)
Linezolid-induced lactic acidosis.
AA Apodaca et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
In vitro bactericidal activities of linezolid in combination with vancomycin, gentamicin, ciprofloxacin, fusidic acid, and rifampin against Staphylococcus aureus
P Grohs et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Efficacies of vancomycin, arbekacin, and gentamicin alone or in combination against methicillin-resistant Staphylococcus aureus in an in vitro infective endocarditis model
DG Lee et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: A meta-analysis
SE Cosgrove et al.
CLINICAL INFECTIOUS DISEASES (2003)
Linezolid vs vancomycin - Analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia
RG Wunderink et al.
CHEST (2003)
Efficacies of quinupristin-dalfopristin combined with vancomycin in vitro and in experimental endocarditis due to methicillin-resistant staphylococcus aureus in relation to cross-resistance to macrolides, lincosamides, and streptogramin B-type antibiotics
J Pavie et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
In vitro activities of quinupristin-dalfopristin and cefepime, alone and in combination with various antimicrobials, against multidrug-resistant staphylococci and enterococci in an in vitro pharmacodynamic model
GP Allen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections
DL Stevens et al.
CLINICAL INFECTIOUS DISEASES (2002)
Accessory gene regulator (agr) locus in geographically diverse Staphylococcus aureus isolates with reduced susceptibility to vancomycin
G Sakoulas et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Synercid plus vancomycin for the treatment of severe methicillin-resistant Staphylococcus aureus and coagulase-negative Staphylococci infections: Evaluation of 5 cases
D Sgarabotto et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2002)
Interactions of quinupristin-dalfopristin with eight other antibiotics as measured by time-kill studies with 10 strains of Staphylococcus aureus for which quinupristin-dalfopristin alone was not bactericidal
PC Fuchs et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Treatment of methicillin-resistant Staphylococcus aureus infections with quinupristin-dalfopristin in patients intolerant of or failing prior therapy
RH Drew et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2000)
Vancomycin and oxacillin synergy for methicillin-resistant staphylococci
BE Domaracki et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
分享论文
